| Accrued Liabilities and other Long-Term Liabilities |
11. Accrued Liabilities and other Long-Term Liabilities
Accrued expenses and other long-term liabilities consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
December 31, |
($ in thousands) |
|
2020 |
|
2019 |
Accrued expenses: |
|
|
|
|
|
|
Professional fees |
|
$ |
1,672 |
|
$ |
1,153 |
Salaries, bonus and related benefits |
|
|
5,677 |
|
|
6,683 |
Accrued expense - related party |
|
|
19 |
|
|
— |
Research and development |
|
|
4,604 |
|
|
4,215 |
Research and development - manufacturing |
|
|
— |
|
|
1,017 |
Research and development - license maintenance fees |
|
|
629 |
|
|
361 |
Research and development - milestones |
|
|
600 |
|
|
— |
Accrued royalties payable |
|
|
1,908 |
|
|
2,320 |
Accrued coupon expense |
|
|
5,476 |
|
|
8,391 |
Other |
|
|
547 |
|
|
1,259 |
Total accrued expenses |
|
$ |
21,132 |
|
$ |
25,399 |
|
|
|
|
|
|
|
Other long-term liabilities: |
|
|
|
|
|
|
Deferred rent and long-term lease abandonment charge1 |
|
$ |
1,996 |
|
$ |
2,136 |
Long-term notes payable, net (Journey) |
|
|
|
|
|
|
Ximino agreement2 |
|
|
3,456 |
|
|
4,990 |
Oral acne treatment agreement3 |
|
|
2,753 |
|
|
— |
Total other long-term liabilities |
|
$ |
8,205 |
|
$ |
7,126 |
Note 1: |
As of September 30, 2020, and December 31, 2019, the balance consists of deferred charges related to build-out of the New York facility. |
Note 2: |
As of September 30, 2020, and December 31, 2019, the imputed interest discount was $1.5 million and $2.0 million, respectively, in connection with its acquisition of Ximino in July 2019. Amortization of interest discount was $0.5 million for the nine months ended September 30, 2020, and $0.1 million for the nine months ended September 30, 2019. As of September 30, 2020, $2.0 million of note payable was classified as short-term. |
Note 3: |
As of September 30, 2020, the imputed discount balance was $0.2 million. The imputed interest discount was calculated utilizing a 4.00% effective rate, which represents the market rate for an asset-backed three year loan, secured by receivables. As of September 30, 2020, $1.0 million of note payable was classified as short-term. |
|